Evidence map›Paper›PMID 41272132›Full record

Observational studyScientific reports2025

Vaccine side effects after vaccination against COVID-19 in employees at an University Hospital in Austria.

Christine Maria Schwarz-Martelanz, Magdalena Hoffmann, Andreas Wedrich, Andrea Berghold, Eva Reininghaus, Sabine Reinisch, Andrea Borenich, Gerald Sendlhofer

Registry-linked trialAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06035926 (Survey of Symptoms After a COVID Vaccination in Employees), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06035926 completednot on this map

Survey of Symptoms After a COVID Vaccination in Employees: a Retrospective Study.

TypeobservationalSponsorMedical University of GrazRan2021 to 2023Enrolled1,093ConditionsSymptoms Recoding SARS-CoV-2 After VaccinationArmsquestionnaire
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christine Maria Schwarz-MartelanzResearch Unit for Safety and Sustainability in Healthcare, c/o Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-0924-2340
Magdalena HoffmannResearch Unit for Safety and Sustainability in Healthcare, c/o Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, Graz, Austria. magdalena.hoffmann@medunigraz.at.ORCID http://orcid.org/0000-0003-1668-4294
Andreas WedrichDepartment of Ophthalmology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-2533-7067
Andrea BergholdInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-5187-9105
Eva ReininghausDivision of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-5964-4087
Sabine ReinischSpecialist Area for Ear, Nose and Throat Medicine, Burgenland Hospitals, Clinic Oberwart, Oberwart, Austria.ORCID http://orcid.org/0000-0002-2506-361X
Andrea BorenichInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-2966-253X
Gerald SendlhoferResearch Unit for Safety and Sustainability in Healthcare, c/o Division of Plastic, Aesthetic and Reconstructive Surgery, Department of Surgery, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-6538-3116

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to investigate symptoms after vaccination with different COVID-19 vaccines reported from employees in an Austrian University hospital. A paper-based survey was conducted among adult employees of an Austrian University Hospital after receiving a first, second or booster dose of a COVID-19 vaccine during January 2021 and January 2022 to identify any side effects reported by participants. The survey further inquired about the participants' demographic information, sick leave or hospitalisation due to the symptoms. Out of the approximately 5000 persons who have been vaccinated, 1093 participants completed the survey. A total of 818 of 1029 employees (79%) reported symptoms after the first, 613 of 1007 employees (61%) reported symptoms after the second and a total of 814 of 974 employees (84%) reported symptoms after booster vaccination. There were differences in the type of vaccination in relation to and number of different symptoms, sick leave as well as anxiety. In conclusion, according to the COVID-19 vaccine type, different side effects might occur following the first, second and booster doses of vaccination. These findings assist in addressing problems of vaccination hesitancy.Trial registration: ClinicalTrials.gov: NCT06035926, 2023-08-28 (retroactively registered).

Indexed as

COVID-19COVID-19 VaccinesVaccinationAdultAnxietyAustriaFemaleHospitals, UniversityHumansImmunization, SecondaryMaleMiddle AgedSARS-CoV-2Sick LeaveSurveys and QuestionnairesYoung AdultCOVID-19 VaccinesCOVID-19Hospital employeesSARS-CoV-2Side effectsVaccine

Identifiers

PMID41272132
PMCPMC12639152

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.